News
This year, beauty technology company Cutera filed for a prepackaged Chapter 11 bankruptcy on March 5 to reduce its debt by ...
The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.
Hims & Hers Health, Inc. (HIMS) Securities Class Actions: The lawsuits allege that Hims & Hers made false and misleading statements while failing to disclose crucial information to investors.
NEW YORK - When it comes to advancing responsible AI deployment, underserved hospitals face a myriad of challenges from cost, interoperability and workforce limitations. Brianna Day, clinical ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC. (HIMS), CLICK HERE BEFORE AUGUST 25, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results